Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 1/20 | 0.63 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.63 |
| ▸ | CA12 | O43570 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | CA4 | P22748 | 2/20 | 0.60 |
| ▸ | CA5A | P35218 | 2/20 | 0.60 |
| ▸ | CA7 | P43166 | 2/20 | 0.60 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.60 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.57 |
| ▸ | LGALS9 | O00182 | 4/20 | 0.57 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.57 |
| ▸ | LGALS1 | P09382 | 3/20 | 0.49 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19664276 | 1.00 | SLC5A1 (0.63) | SLC5A1SLC5A2CA12CA1CA2 | |
| SCHEMBL5326843 | 1.00 | SLC5A1 (0.63) | SLC5A1SLC5A2CA12CA1CA2 | |
| SCHEMBL10933223 | 1.00 | SLC5A1 (0.63) | SLC5A1SLC5A2CA12CA1CA2 | |
| SCHEMBL11058689 | 0.90 | CA12 (0.64) | SLC5A1SLC5A2CA12CA1CA2 | |
| SCHEMBL11050894 | 0.88 | SLC5A1 (0.53) | SLC5A1SLC5A2CA12CA1CA2 | |
| SCHEMBL3322973 | 0.84 | CA12 (0.64) | SLC5A2CA12CA1CA2CA4 | |
| SCHEMBL19818850 | 0.84 | CA12 (0.64) | SLC5A2CA12CA1CA2CA4 | |
| SCHEMBL3824089 | 0.84 | CA12 (0.64) | SLC5A2CA12CA1CA2CA4 | |
| SCHEMBL17683647 | 0.84 | CA12 (0.64) | SLC5A2CA12CA1CA2CA4 | |
| SCHEMBL2163405 | 0.84 | CA12 (0.64) | SLC5A2CA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007128480-A2 | THIOGLYCOSIDES AS PHARMACEUTICALLY ACTIVE AGENTS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-11-15 | — | — | WO | claimed |
| WO-2007128480-A2 | THIOGLYCOSIDES AS PHARMACEUTICALLY ACTIVE AGENTS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-11-15 | — | — | WO | disclosed |